-
This week in therapeutics Indication Target/marker/pathway Summary Licensing status Publication and contact information Cancer Cancer Interferon-b (IFNB; IFN-b) Mouse studies suggest a synthetic sialyl-IFNB …
Published on 3/29/2012
-
This week in therapeutics Indication Target/marker/pathway Summary Licensing status Publication and contact information Cancer Cancer Not applicable In vitro and mouse studies identified an isomer of 2-(4-…
Published on 3/29/2012
-
This week in therapeutics Indication Target/marker/pathway Summary Licensing status Publication and contact information Cancer Cancer Ras-related C3 botulinum toxin substrate 1 (rho family, small GTP binding …
Published on 3/29/2012
-
This week in therapeutics Indication Target/marker/pathway Summary Licensing status Publication and contact information Cancer Lymphoma Epstein-Barr nuclear antigen 3B (EBNA3B) Mouse and patient sample …
Published on 3/29/2012
-
This week in therapeutics Indication Target/marker/pathway Summary Licensing status Publication and contact information Cancer Ovarian cancer Leukotriene B4 type 2 receptor (BLT2) In vitro and mouse studies …
Published on 3/29/2012
-
This week in therapeutics Indication Target/marker/pathway Summary Licensing status Publication and contact information Cardiovascular disease Fibrillation; arrhythmia Potassium channel Kv1.5 (KCNA5) In vitro…
Published on 3/29/2012
-
This week in therapeutics Indication Target/marker/pathway Summary Licensing status Publication and contact information Dermatology Dermatitis Cysteinyl leukotriene receptor 2 (CYSLTR2; CysLT2); leukotriene C4…
Published on 3/29/2012
-
This week in therapeutics Indication Target/marker/pathway Summary Licensing status Publication and contact information Endocrine/metabolic disease Diabetes Sphingosine-1-phosophate phosphatase 1 (SGPP1) Cell…
Published on 3/29/2012
-
This week in therapeutics Indication Target/marker/pathway Summary Licensing status Publication and contact information Endocrine/metabolic disease Metabolic syndrome; obesity Fructokinase (ketohexokinase; KHK…
Published on 3/29/2012
-
This week in therapeutics Indication Target/marker/pathway Summary Licensing status Publication and contact information Endocrine/metabolic disease Obesity Phosphoinositide 3-kinase (PI3K); PI3Ka; PI3Kd; PTEN…
Published on 3/29/2012
-
This week in therapeutics Indication Target/marker/pathway Summary Licensing status Publication and contact information Gastrointestinal disease Colitis Leucine-rich repeat-containing G protein-coupled …
Published on 3/29/2012
-
This week in therapeutics Indication Target/marker/pathway Summary Licensing status Publication and contact information Musculoskeletal disease Osteoporosis Not applicable In vitro and mouse studies suggest …
Published on 3/29/2012
-
This week in therapeutics Indication Target/marker/pathway Summary Licensing status Publication and contact information Neurology Neuroinflammation Cannabinoid CB2 receptor (CNR2) Tissue, cell culture and …
Published on 3/29/2012
-
This week in therapeutics Indication Target/marker/pathway Summary Licensing status Publication and contact information Neurology Rett syndrome Not applicable Mouse studies suggest bone marrow transplantation…
Published on 3/29/2012
-
This week in therapeutics Indication Target/marker/pathway Summary Licensing status Publication and contact information Neurology Stroke Hydrogen voltage-gated channel 1 (HVCN1) Studies in cell culture and in…
Published on 3/29/2012
-
This week in therapeutics Indication Target/marker/pathway Summary Licensing status Publication and contact information Neurology Stroke Prokineticin 2 (PROK2; Bv8); prokineticin receptor 2 (PROKR2; PKR2) Rat…
Published on 3/29/2012
-
This week in therapeutics Indication Target/marker/pathway Summary Licensing status Publication and contact information Transplantation Graft-versus-host disease (GvHD) MicroRNA-155 (miR-155) Mouse studies …
Published on 3/29/2012
-
Indication Target/marker/pathway Summary Licensing status Publication and contact information Infectious disease Ebola v-abl Abelson murine leukemia viral oncogene homolog 1 (ABL1) Cell culture studies suggest…
Published on 3/22/2012
-
Indication Target/marker/pathway Summary Licensing status Publication and contact information Infectious disease Malaria Not applicable In vitro studies suggest hybrid macrolide antibiotic-quinoline compounds …
Published on 3/22/2012
-
Indication Target/marker/pathway Summary Licensing status Publication and contact information Musculoskeletal disease Muscular dystrophy Dystrophia myotonica-protein kinase (DMPK; DM1); RNaseH Mouse and cell …
Published on 3/22/2012
-
Indication Target/marker/pathway Summary Licensing status Publication and contact information Neurology Alzheimer's disease (AD); cognitive dysfunction Microtubule-associated protein-t (MAPT; TAU; FTDP-17) …
Published on 3/22/2012
-
Indication Target/marker/pathway Summary Licensing status Publication and contact information Neurology Multiple sclerosis (MS) Neurotrophic tyrosine kinase receptor 2 (NTRK2; TrkB) Patient sample and mouse …
Published on 3/22/2012
-
Indication Target/marker/pathway Summary Licensing status Publication and contact information Neurology Nerve damage Chondroitin sulfate proteoglycan (CSPG); chondroitin sulphate E (CS-E) In vitro and mouse …
Published on 3/22/2012
-
Indication Target/marker/pathway Summary Licensing status Publication and contact information Pain Transient receptor potential cation channel subfamily M member 2 (TRPM2) Studies in mice suggest inhibiting …
Published on 3/22/2012
-
Indication Target/marker/pathway Summary Licensing status Publication and contact information Renal disease Renal damage Homeodomain interacting protein kinase 2 (HIPK2) Patient tissue and mouse studies …
Published on 3/22/2012